What is GILD stock price today?

GILD (Gilead Sciences Inc) stock is trading at $131.40 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is GILD stock going up or down today?

GILD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GILD stock now?

The decision to buy GILD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GILD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GILD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GILD stock overvalued or undervalued?

GILD currently trades at a P/E ratio of 17.55 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if GILD is fairly priced.

What is GILD's P/E ratio?

GILD has a price-to-earnings (P/E) ratio of 17.55, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GILD's market cap?

GILD (Gilead Sciences Inc) has a market capitalization of $160.15 billion, making it a mid-cap stock.

What is GILD's price to book ratio?

Price-to-book ratio for GILD is available on our dashboard along with other valuation metrics.

Does GILD pay dividends?

Yes, GILD pays dividends with a current yield of 2.50%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is GILD's dividend yield?

GILD's dividend yield is 2.50%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is GILD stock a good long-term investment?

GILD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GILD's revenue growth rate?

Revenue growth data for GILD is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GILD are available on our dashboard with complete income statement analysis.

What are the risks of investing in GILD?

Key risks for GILD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GILD compare to its competitors?

Compare GILD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GILD's performance and positioning.

What is GILD's stock price target for 2026?

Our AI model provides price targets for GILD based on fundamental analysis: Bull case $170.82 (+30%), Base case $151.11 (+15%), Bear case $118.26 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about GILD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GILD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GILD's next earnings report?

GILD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GILD - Gilead Sciences Inc

NYSE * Healthcare * Drug Manufacturers - General

$131.40

+$1.57 (+1.21%)

About Gilead Sciences Inc

Gilead Sciences Inc (GILD) common stock

Price Chart

Loading chart...

GILD Key Statistics

Market Cap

$160.15B

P/E Ratio

17.55

Dividend Yield

2.50%

How GILD Compares to Peers

GILD ranks 2nd most undervalued by P/E ratio among peers

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GILD(This stock)	$160.15B	17.5	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 1:15 AM EDT

Ready to invest in GILD?

Commission-free trading available. Affiliate links.

GILD Lician Score

14% confidence

4.0/10

Neutral

GILD has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates GILDacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

GILD Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for GILD

Dashboard

Enter a ticker to analyze